NVCT Surges 20%
Nuvectis Pharma's stock surges 20% after announcing a strategic portfolio expansion through a license agreement with Haisco Pharmaceutical Group
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Nuvectis Pharma's stock surges 20% after announcing a strategic portfolio expansion through a license agreement with Haisco Pharmaceutical Group
Nexentis Technologies' stock soars 156% before falling 46% after hours